Tao-Wei Ke

机构：China Medical University, China Medical University Hospital

发表论文 1 篇

代表论文

• A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA–positive colorectal cancer. (2026 · Journal of Clinical Oncology)